Lonza reveals process development roadmap for cell and gene therapies

Behnam Baghbaderani of Lonza Pharma & Biotech examines four manufacturing challenges inherent to the production of ...

Argonaut launches aseptic vial filling services for biopharmaceuticals

A California-based CDMO has designed an aseptic filling line to maximise yield of expensive biologics and other high- ...

Bristol-Myers Squibb and Catalent close Italian manufacturing deal

Former BMS manufacturing and packaging facility in Anagni is now under Catalent ownership

Manufacturing Chemist roundtable: Pharmaceutical trends to keep an eye on

From cannabis to containment and from regulatory affairs to Russia, 2019 presented the pharmaceutical industry with a ...

Tessa to build commercial-scale cell therapy production site in Singapore

The clinical-stage cell therapy company plans to open a 90,000 square foot facility by year-end

WuXi STA opens oligonucleotide large-scale manufacturing facility

API production at the Changzhou site can manufacture oligonucleotide ingredients up to 1 mol/synthesis run

Boehringer is first to take advantage of new Chinese regulations

Tislelizumab is the first biopharmaceutical manufactured by a multinational CDMO in China and the first commissioned ...

AGC expands plasmid DNA capacity in Germany

ACG’s Heidelberg site has completed a pDNA manufacturing process improvement project that expands the service in ...

Expanded access and commercial packaging for niche-market drugs

Securing timely and reliable commercial packaging services can be challenging for orphan, niche and other low-volume ...

Future innovations in pharmaceutical contract manufacturing

In the final part of our roundtable, panellists look at current drivers and assess the long-term interest in on-trend ...

Chinese government recognises Catalent

The Chinese government has acknowledged Catalent’s successful investment and operations in the Tangzhen region

Swedish biotech chooses Recipharm for sepsis drug manufacturing

Recipharm has signed a deal with Aptahem to develop an injectable formulation for an upcoming Phase 1 study

Catalent launches direct-to-patient clinical supply services

Rephine announces symposium in January specialising on GMP and GCP

Recipharm begins production of soon-to-be-launched Talicia

Recipharm launches Analytical Solutions to support pharmaceutical companies with QC requirements

Bora appoints President to strengthen North American team

ACGcaps HA debuts at CPhI Worldwide

Making Pharmaceuticals

Catalent latest technology improves titers and cell-specific productivity

Primex Pharmaceuticals appoints new Global Commerical Head

Aston Particle Technologies boosts R&D with new benchtop systems

Wasdell Ireland HQ starts operation

Almac Group reports further growth during period of global expansion

Dizal Pharma chooses WuXi STA for GMP production from API to drug product

Catalent appoints new German General Manager of clinical supply facility

White paper: Optimising speed-to-market with flexible manufacturing processes

Lonza offers service to increase bioavailability

Catalent to increase dose form capabilities at Winchester site